Sam Aiyad Ali MD , Naja Emborg Vinding MD , Jawad H. Butt MD , Johanna Krøll MD , Johan E. Larsson MD , Morten Schou MD, PhD , Emil L. Fosbøl MD, PhD , Brian B. Løgstrup MD, PhD, DMsc , Inge Schjødt RN, PhD , Pardeep S. Jhund MD , Lars Køber MD, DMSc , Finn Gustafsson MD, DMSc , Naveed Sattar MBChB, PhD , John J.V. McMurray MD , Søren Lund Kristensen MD, PhD
{"title":"Disparities Among Immigrants and Native Patients in Denmark With New-Onset Heart Failure With Reduced Ejection Fraction","authors":"Sam Aiyad Ali MD , Naja Emborg Vinding MD , Jawad H. Butt MD , Johanna Krøll MD , Johan E. Larsson MD , Morten Schou MD, PhD , Emil L. Fosbøl MD, PhD , Brian B. Løgstrup MD, PhD, DMsc , Inge Schjødt RN, PhD , Pardeep S. Jhund MD , Lars Køber MD, DMSc , Finn Gustafsson MD, DMSc , Naveed Sattar MBChB, PhD , John J.V. McMurray MD , Søren Lund Kristensen MD, PhD","doi":"10.1016/j.jchf.2024.11.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Worldwide, major health care variations exist in patients with heart failure (HF).</div></div><div><h3>Objectives</h3><div>In this study, the authors sought to examine and compare immigrants grouped by region of origin and native Danish patients presenting with new-onset heart failure with reduced ejection fraction (HFrEF).</div></div><div><h3>Methods</h3><div>The authors used data from the Danish Heart Failure Registry and administrative registries comprising information on medication, comorbidity, vital status, income level, and education. The co-primary outcomes were uptitration of guideline-directed medical therapy (GDMT) and a composite of HF hospitalization and all-cause death.</div></div><div><h3>Results</h3><div>Overall, 55,918 patients were included, of whom 94.8% were native Danish patients, 3.0% originated from Europe/Central Asia, 1.1% from the Middle East/North Africa, 0.6% from South Asia, and 0.5% from other regions. Patients from the non-Western areas were around 10 years younger (median age 62 vs 72 years) and had more diabetes (38%-50% vs 20%) and ischemic heart disease (67%-74% vs 48%) and less atrial fibrillation (9%-15% vs 32%) compared with Danish patients (all <em>P</em> < 0.001). At 12 months’ follow-up, no major differences in attainment of ≥50% target daily doses of GDMT were observed across groups. The crude 3-year cumulative risk of HF hospitalization or all-cause death ranged from 25% to 37% and was lowest for non-Western immigrants, although this difference does not persist in age- and sex-matched analyses.</div></div><div><h3>Conclusions</h3><div>Patients in Denmark with HFrEF originating from non-Western parts of the world were younger and had more ischemic heart disease and diabetes and less atrial fibrillation compared with native Danish patients. The likelihood of GDMT uptitration at 12 months was similar to that of native Danish patients, whereas their risk of HF hospitalization or all-cause death was lower, although the difference between the 2 groups diminished in age- and sex-matched analyses.</div></div>","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 3","pages":"Pages 483-493"},"PeriodicalIF":11.8000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Heart failure","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213177924008710","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Worldwide, major health care variations exist in patients with heart failure (HF).
Objectives
In this study, the authors sought to examine and compare immigrants grouped by region of origin and native Danish patients presenting with new-onset heart failure with reduced ejection fraction (HFrEF).
Methods
The authors used data from the Danish Heart Failure Registry and administrative registries comprising information on medication, comorbidity, vital status, income level, and education. The co-primary outcomes were uptitration of guideline-directed medical therapy (GDMT) and a composite of HF hospitalization and all-cause death.
Results
Overall, 55,918 patients were included, of whom 94.8% were native Danish patients, 3.0% originated from Europe/Central Asia, 1.1% from the Middle East/North Africa, 0.6% from South Asia, and 0.5% from other regions. Patients from the non-Western areas were around 10 years younger (median age 62 vs 72 years) and had more diabetes (38%-50% vs 20%) and ischemic heart disease (67%-74% vs 48%) and less atrial fibrillation (9%-15% vs 32%) compared with Danish patients (all P < 0.001). At 12 months’ follow-up, no major differences in attainment of ≥50% target daily doses of GDMT were observed across groups. The crude 3-year cumulative risk of HF hospitalization or all-cause death ranged from 25% to 37% and was lowest for non-Western immigrants, although this difference does not persist in age- and sex-matched analyses.
Conclusions
Patients in Denmark with HFrEF originating from non-Western parts of the world were younger and had more ischemic heart disease and diabetes and less atrial fibrillation compared with native Danish patients. The likelihood of GDMT uptitration at 12 months was similar to that of native Danish patients, whereas their risk of HF hospitalization or all-cause death was lower, although the difference between the 2 groups diminished in age- and sex-matched analyses.
背景:在世界范围内,心力衰竭(HF)患者存在主要的医疗保健差异。目的:在这项研究中,作者试图检查和比较按原籍地区分组的移民和丹麦本土患者出现新发心力衰竭并降低射血分数(HFrEF)。方法:作者使用来自丹麦心力衰竭登记处和行政登记处的数据,包括药物、合并症、生命状态、收入水平和教育等信息。共同主要结局是指南导向药物治疗(GDMT)的提高以及HF住院和全因死亡的综合结果。结果:总体纳入55,918例患者,其中94.8%为丹麦本土患者,3.0%来自欧洲/中亚,1.1%来自中东/北非,0.6%来自南亚,0.5%来自其他地区。与丹麦患者相比,来自非西方地区的患者大约年轻10岁(中位年龄62岁vs 72岁),糖尿病(38%-50% vs 20%)和缺血性心脏病(67%-74% vs 48%)发生率更高,房颤发生率更低(9%-15% vs 32%)(均P < 0.001)。在12个月的随访中,各组在达到≥50%的GDMT目标日剂量方面没有观察到重大差异。3年心力衰竭住院或全因死亡的累积风险从25%到37%不等,非西方移民最低,尽管这种差异在年龄和性别匹配分析中并不存在。结论:与丹麦本土患者相比,来自世界非西方地区的丹麦HFrEF患者更年轻,缺血性心脏病和糖尿病发生率更高,房颤发生率更低。12个月时GDMT升高的可能性与丹麦本土患者相似,而他们HF住院或全因死亡的风险较低,尽管两组之间的差异在年龄和性别匹配分析中减小。
期刊介绍:
JACC: Heart Failure publishes crucial findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal is to enhance understanding through timely scientific communication on disease, clinical trials, outcomes, and therapeutic advances. The Journal fosters interdisciplinary connections with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery related to heart failure. It also covers articles on pharmacogenetics, biomarkers, and metabolomics.